Biotia

Sepsis Awareness: The Current Global Health Crisis and What We Can Do About It

Sepsis kills 11 million people each year. Faster, broader pathogen ID could change the outcome.

Dorottya Nagy-Szakal, MD, PhDChief Medical Officer • Biotia
Sep 2022 · 8 min read

Sepsis is one of the leading causes of death worldwide. The World Health Organization estimates it accounts for one in every five deaths — roughly 11 million people each year. For a problem of that scale, sepsis receives strikingly little public attention.

What sepsis actually is

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. It can begin from a urinary tract infection, pneumonia, an abdominal infection, or even a minor skin wound. Without prompt, appropriate antibiotic therapy and supportive care, sepsis progresses rapidly to septic shock and death.

Why current diagnostics fall short

Blood culture remains the standard for identifying the causative organism in sepsis, but it has serious limitations. Cultures take 24–72 hours to return a result, frequently fail to grow anything at all, and are easily compromised if the patient has already received antibiotics — which is almost always the case.

While clinicians wait, they must treat empirically with broad-spectrum antibiotics. That saves lives in the short term, but it also fuels antimicrobial resistance and exposes patients to unnecessary drug toxicity.

The case for sequencing-based pathogen ID

Metagenomic next-generation sequencing reads microbial DNA directly from clinical samples. It does not require organisms to grow, so fastidious bacteria, fungi, and viruses can all be detected from a single sample — alongside the resistance genes they carry, increasingly with help from AI-powered analysis. The result is a far more comprehensive picture, returned faster than serial culture rounds.

For sepsis specifically, this matters because every hour of delay in appropriate therapy raises mortality. Closing the diagnostic window is among the highest-leverage interventions available.

What it takes to actually fix this

Better sepsis outcomes require three things: faster, broader pathogen identification; disciplined antibiotic stewardship that uses that information to narrow therapy; and education so that clinicians, patients, and families recognize sepsis early. Biotia's sequencing-based assays are designed for the first of those — closing the diagnostic gap so the rest of the system has something accurate to act on.

Frequently asked questions

What is sepsis?

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Without prompt, appropriate treatment, it progresses rapidly to septic shock and death.

Why is sepsis so deadly?

Time is the central problem. Each hour of delay in appropriate antibiotic therapy increases mortality. Standard blood culture often takes 24–72 hours to return a result — and frequently returns nothing at all.

How can metagenomic sequencing help?

Sequencing reads pathogen DNA directly from blood or other clinical samples without requiring bacterial growth. That makes it possible to identify the causative organism, including fastidious or unculturable ones, much faster — and to detect resistance genes alongside it.

Related reading